TMC Life Sciences Berhad reported earnings results for the third quarter and nine months ended March 31, 2025. For the third quarter, the company reported sales was MYR 89.87 million compared to MYR 86.07 million a year ago. Net loss was MYR 0.806 million compared to net income of MYR 9.96 million a year ago. Basic loss per share from continuing operations was MYR 0.0005 compared to basic earnings per share from continuing operations of MYR 0.0057 a year ago. Diluted loss per share from continuing operations was MYR 0.0005 compared to diluted earnings per share from continuing operations of MYR 0.0057 a year ago.
For the nine months, sales was MYR 252.27 million compared to MYR 272.29 million a year ago. Net income was MYR 1.18 million compared to MYR 39.62 million a year ago. Basic earnings per share from continuing operations was MYR 0.0007 compared to MYR 0.0227 a year ago. Diluted earnings per share from continuing operations was MYR 0.0007 compared to MYR 0.0227 a year ago.